Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Development of drug resistance to HIV-1 protease inhibitors.

× No keyword cloud information.

28 in total

1. Genetic variability of HIV-1 protease from Nigeria and correlation with protease inhibitors drug resistance.

Authors: A C Vicente; S M Agwale; K Otsuki; O M Njouku; D Jelpe; J A Idoko; E Caride; R M Brindeiro; A Tanuri
Journal: Virus Genes Date: 2001-03 Impact factor: 2.332

2. Inhibition of the HIV-1 and HIV-2 proteases by a monoclonal antibody.

Authors: J Lescar; J Brynda; P Rezacova; R Stouracova; M M Riottot; V Chitarra; M Fabry; M Horejsi; J Sedlacek; G A Bentley
Journal: Protein Sci Date: 1999-12 Impact factor: 6.725

3. Saquinavir inhibits early events associated with establishment of HIV-1 infection: potential role for protease inhibitors in prevention.

Authors: Martha Stefanidou; Carolina Herrera; Naomi Armanasco; Robin J Shattock
Journal: Antimicrob Agents Chemother Date: 2012-06-04 Impact factor: 5.191

4. Sensitive genetic screen for protease activity based on a cyclic AMP signaling cascade in Escherichia coli.

Authors: N Dautin; G Karimova; A Ullmann; D Ladant
Journal: J Bacteriol Date: 2000-12 Impact factor: 3.490

5. HIV-1 protease with 20 mutations exhibits extreme resistance to clinical inhibitors through coordinated structural rearrangements.

Authors: Johnson Agniswamy; Chen-Hsiang Shen; Annie Aniana; Jane M Sayer; John M Louis; Irene T Weber
Journal: Biochemistry Date: 2012-03-20 Impact factor: 3.162

6. Combination antiretroviral therapy in HIV infection. An economic perspective.

Authors: R D Moore; J G Bartlett
Journal: Pharmacoeconomics Date: 1996-08 Impact factor: 4.981

7. Development of a novel anti-HIV-1 agent from within: effect of chimeric Vpr-containing protease cleavage site residues on virus replication.

Authors: D Serio; T A Rizvi; M Cartas; V S Kalyanaraman; I T Weber; H Koprowski; A Srinivasan
Journal: Proc Natl Acad Sci U S A Date: 1997-04-01 Impact factor: 11.205

8. Genetic variation and susceptibilities to protease inhibitors among subtype B and F isolates in Brazil.

Authors: A Tanuri; A C Vicente; K Otsuki; C A Ramos; O C Ferreira; M Schechter; L M Janini; D Pieniazek; M A Rayfield
Journal: Antimicrob Agents Chemother Date: 1999-02 Impact factor: 5.191

9. Quantitative assessment of HIV-1 protease inhibitor interactions with drug efflux transporters in the blood-brain barrier.

Authors: Corbin J Bachmeier; Timothy J Spitzenberger; William F Elmquist; Donald W Miller
Journal: Pharm Res Date: 2005-08-03 Impact factor: 4.200

10. Analysis and characterization of dimerization inhibition of a multi-drug-resistant human immunodeficiency virus type 1 protease using a novel size-exclusion chromatographic approach.

Authors: David A Davis; Irene R Tebbs; Sarah I Daniels; Stephen J Stahl; Joshua D Kaufman; Paul Wingfield; Michael J Bowman; Jean Chmielewski; Robert Yarchoan
Journal: Biochem J Date: 2009-04-15 Impact factor: 3.857